Document is current
Any future updates will be listed below
-
Authors
Jones, Tarsha
Silverman, Thomas
Guzman, Ashlee
McGuinness, Julia E.
Trivedi, Meghna S.
Kukafka, Rita
Crew, Katherine D.
-
Funding
Funding for this research was provided by:
National Cancer Institute (1K01CA241393-01A1)
National Cancer Institute (ClinicalTrials.gov Identifier: NCT03069742)
National Cancer Institute (ClinicalTrials.gov Identifier: NCT03069742)
National Cancer Institute (ClinicalTrials.gov Identifier: NCT03069742)
National Cancer Institute (ClinicalTrials.gov Identifier: NCT03069742)
National Cancer Institute (ClinicalTrials.gov Identifier: NCT03069742)
National Cancer Institute (ClinicalTrials.gov Identifier: NCT03069742)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
Division of Cancer Prevention, National Cancer Institute (R01 CA177995-01A1)
NCI (R01CA177995-05S1)
NCI (R01CA177995-05S1)
- License Information
-
More Information
Article History
Received: 25 February 2022
Accepted: 26 July 2022
First Online: 4 August 2022
Declarations
:
: The study protocols were approved by the Institutional Review board of Columbia University. Informed consent was obtained for all subjects. All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki). There were no experiments included in this study.
: Not applicable.
: The authors declare that they have no competing interests.
